Full Breakdown
Rapid Genomic Test Slashes Brain-Tumour Diagnosis Time in NHS Pilot
By Drooid · · How we work
The Pilot Launch: Intra-operative Genomic Testing
A rapid genomic test from the Brain Tumour Research Centre of Excellence at the University of Nottingham can deliver a tumour-type diagnosis while the patient remains on the operating table. Small tissue samples are sequenced on a portable Oxford Nanopore device, revealing the genetic profile within two hours. NHS England is piloting the test in five specialist centres—Nottingham University Hospitals NHS Trust, University Hospitals Birmingham NHS Foundation Trust, Great Ormond Street Hospital NHS Foundation Trust, King’s College Hospital, and Newcastle Hospitals NHS Foundation Trust—before extending it to sites in Bristol, Oxford, Leeds and Manchester.
Background & Context
Brain tumours are difficult to identify because more than 100 distinct forms exist, ranging from benign lesions to aggressive cancers. Primary brain tumours are the leading cause of cancer death among children and adults under 40 in the United Kingdom. Conventional diagnosis relies on imaging followed by microscopic pathology, a process that can take weeks and leaves patients and families in prolonged uncertainty.
Data & Statistics
- Traditional pathways can require up to eight weeks for a definitive result.
- The rapid test reduces this interval to approximately two hours, enabling intra-operative decision-making.
- Over a quarter of patients currently wait more than a month after surgery to learn their tumour type.
- NHS England has committed more than £2 million over two years to the Brain Cancer NHS Genomic Network of Excellence, which oversees the test’s development and rollout.
Official Statements & Responses
Professor Frankie Swords described the test as a “huge leap forward for patients.” Health Secretary Yvette Cooper called it an “incredible breakthrough.” Dr Karen Noble noted that faster testing could improve access to clinical trials, especially for aggressive disease forms. Simon Newman highlighted that many patients endure weeks of anxiety while awaiting a diagnosis.
On-the-Ground Report
Steve Palmer, a 55-year-old patient from Nottingham diagnosed with a grade 4 glioblastoma, said the rapid result allowed his treatment plan to be established quickly, removing weeks of anxiety that would otherwise have accompanied the waiting period.
Verbatim Quotes
- “This remarkable rapid test has the potential to completely transform how we diagnose brain tumours, with results reaching patients in a matter of days rather than weeks.” — Professor Frankie Swords
- “Mr Palmer said: "For me, getting that quick diagnosis of exactly what type of tumour I had was a key thing, because it meant we could get the treatment plan in place very rapidly.” — Steve Palmer
- “This is an incredible breakthrough in the technology available to tackle brain tumours.” — Yvette Cooper
What’s Next
The first phase of the pilot will expand to additional hospitals in Birmingham, London and Newcastle. A second phase will introduce further genomic laboratory sites, extending the service to more regions across England. NHS England plans to build evidence for routine adoption, aiming for nationwide availability of the rapid test in the coming years.